On this episode of The Road to Care, we’re joined by Luba Sobolevsky, PharmD, IgCP®, President & CEO of the Immunoglobulin National Society (IgNS), and Amy E. Clarke, DNP, RN, IgCN®, Chief Clinical Officer at IgNS, two nationally recognized leaders advancing standards, education, certification, and patient advocacy in immunoglobulin (IG) therapy and biologics.

Dr. Sobolevsky and Dr. Clarke walk through how IgNS built an interdisciplinary model including standards, education, certification (IgCN®/IgCP®), and outcomes research, to close dangerous training gaps in IG therapy, and preview what’s next as the pipeline accelerates (FcRn and complement inhibitors, hyaluronidase-facilitated SCIG), the workforce ages, and plasma supply and site-of-care complexity grow.

Tune in to learn:

-Why certification matters (IgCN®/IgCP®) as a measurable competency metric tied to safer infusions and better outcomes.

-The power of interdisciplinary education across nurses, pharmacists, and physicians—and how to embed standards into policy and practice.

-What’s changing in IG therapy: new biologics, site-of-care variability (home, AICs, hospital), and implications for clinician training and patient experience.

-Patient voice as a “fourth pillar”—how shared decision-making and outcomes research inform continuous improvement.

Together, we can make healthcare right. Here are some of the outstanding organizations and associations championing patient health mentioned in this episode:

Immunoglobulin National Society (IgNS): https://ig-ns.org

National Infusion Center Association (NICA): https://infusioncenter.org/

Infusion Nurses Society (INS): https://www.ins1.org/

For more information on SamaCare’s free prior authorization management platform for specialty practices, visit https://www.samacare.com/?utm_source=podcast&utm_medium=r2c

This podcast was produced by JFACTOR for SamaCare. Learn more at https://www.jfactor.com/